Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Clinical trial NCT01451268 · UNKNOWN
Trial details
- NCT number
- NCT01451268
- Sponsor
- Johann Wolfgang Goethe University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2018-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.